MD Anderson names 1st chief scientific officer: 6 things to know

The University of Texas MD Anderson Cancer Center in Houston selected Giulio Draetta, MD, PhD, to serve as chief scientific officer, a new role.

Advertisement

Six things to know:

1. Dr. Draetta joined MD Anderson in 2011.

2. He most recently served as senior vice president for discovery and platforms and then chief academic officer, ad interim, for MD Anderson.

3. He also spent time as co-leader of MD Anderson’s Moon Shots Program and vice president of the therapeutics discovery division.

4. Dr. Draetta maintains his faculty appointment as the Sewell Family Chair in the department of genomic medicine’s cancer medicine at MD Anderson.

5. He has prior experience working at Pharmacia and Merck, and has also co-founded and led biotechnology companies.

6. In his new role, Dr. Draetta will drive innovation and partnerships as well as oversee the science and clinical translation of research programs.

More articles on executive moves:
11 latest hospital, health system CEO moves
Penn State Health selects new CEO: 7 things to know
Mercy Health-Fairfield Hospital CEO steps down

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Executive Moves

Advertisement

Comments are closed.